Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

539743 InhibitorSelect™ 384-Well Protein Kinase Inhibitor Library I - Calbiochem

InhibitorSelect™ 384-Well Protein Kinase Inhibitor Library I contains 160 well-characterized, cell-permeable, potent, reversible protein kinase inhibitors; the majority of which are ATP-competitive.

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
539743
  
Purchase on Sigma-Aldrich

Overview

Replacement Information
Description
Overview

This product has been discontinued.



The InhibitorSelect™ 384-Well Protein Kinase Inhibitor Library I consists of 160 well-characterized, cell-permeable, potent, and reversible protein kinase inhibitors; the majority of which are ATP-competitive. They are supplied in a convenient 384-well plate format at a concentration of 10 mM in DMSO. The inhibitors in this library will be useful for target identification in drug discovery, biochemical pathway analysis, high-throughput kinase profiling, and other pharmaceutical-related applications.
Supplied with a CD containing comprehensive documentation for each inhibitor. Please contact technical service for further details.

Download a list of all inhibitors of library I, including a comprehensive data set.
Catalogue Number539743
Brand Family Calbiochem®
Application Data

**Total higher than 160, as some inhibitors target kinases in other branches as well. TK: Tyrosine Kinase Group TKL: Tyrosine Kinase-Like Group AGC: PKA, PKG, and PKC Containing Group CMGC: Cdk, MAPK, GSK3, and CLK Containing Group CAMK: Ca2+/Calmodulin Dependent Protein Kinases CK: Casein Protein Kinases STE: Yeast Sterile Protein Kinases
References
Product Information
Form384-well plate
FormulationAll of the inhibitors, except for one, are supplied at a concentration of 10 mM in DMSO (25 µl/well).
Hygroscopic Hygroscopic
Applications
Biological Information
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Dry Ice Only
Toxicity Regulatory Review
Storage ≤ -70°C
Protect from Light Protect from light
Hygroscopic Hygroscopic
Avoid freeze/thaw Avoid freeze/thaw
Do not freeze Ok to freeze
Special InstructionsPlease note that the contents of the resealable bag have been purged under nitrogen. Open the bubble pouch and the resealable bag. Remove the plate from the bag, and let it thaw at room temperature. Remove the lid and mat gently. For long-term storage, tightly reseal with the mat, place in the resealable bag and purge with an inert gas. Store at -70°C in an upright position. Minimize freeze/thaw cycles. Product is stable for up to one year after receipt.
Packaging Information
Packaged under inert gas Packaged under inert gas
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalogue Number GTIN
539743 0

Documentation

InhibitorSelect™ 384-Well Protein Kinase Inhibitor Library I - Calbiochem SDS

Title

Safety Data Sheet (SDS) 

InhibitorSelect™ 384-Well Protein Kinase Inhibitor Library I - Calbiochem Certificates of Analysis

TitleLot Number
539743

Data Sheet

Title
Reprogramming Cell Fate and Function Novel Strategies for iPSC Generation, Characterization, and Differentiation

Citations

Title
  • Anastassiadis, T., et al. 2011. Nature Biotech. 29, 1039.
  • Cohen, T., et al. 2012. Biochem. J. in press.
  • Elkaim, J., 2012. Biochem. J. in press.
  • Baxter, B.K., et al. 2011. ACS Chem. Biol. in press.
  • Lanier, m. et al. 2011. J. Med. Chem. DOI: 10.1021/jm2010223.
  • Wong, S.W., et al. 2010. Breast Cancer Res. Treat. in press.
  • Chou, T-F. and Deshaies, R.J., 2011. JBC Papers in Press.
  • Li, T., et al. 2010. Anal. Chem. 82, 3067.
  • Johnson, J.L., et al. 2009.BMC Microbiol. 9, 218.
    		•
    Data Sheet

    Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

    Revision11-September-2012 JSW
    Application Data

    **Total higher than 160, as some inhibitors target kinases in other branches as well. TK: Tyrosine Kinase Group TKL: Tyrosine Kinase-Like Group AGC: PKA, PKG, and PKC Containing Group CMGC: Cdk, MAPK, GSK3, and CLK Containing Group CAMK: Ca2+/Calmodulin Dependent Protein Kinases CK: Casein Protein Kinases STE: Yeast Sterile Protein Kinases
    DescriptionThe InhibitorSelect™ 384-Well Protein Kinase Inhibitor Library I consists of 160 well-characterized, cell-permeable, potent, and reversible protein kinase inhibitors; the majority of which are ATP-competitive. They are supplied in a convenient 384-well plate format at a concentration of 10 mM in DMSO. The inhibitors in this library will be useful for target identification in drug discovery, biochemical pathway analysis, high-throughput kinase profiling, and other pharmaceutical-related applications. Supplied with a CD containing comprehensive documentation for each inhibitor. Please contact technical service for further details.
    Form384-well plate
    FormulationAll of the inhibitors, except for one, are supplied at a concentration of 10 mM in DMSO (25 µl/well).
    Intert gas (Yes/No) Packaged under inert gas
    Storage Protect from light
    Avoid freeze/thaw
    ≤ -70°C
    Hygroscopic
    Do Not Freeze Ok to freeze
    Special InstructionsPlease note that the contents of the resealable bag have been purged under nitrogen. Open the bubble pouch and the resealable bag. Remove the plate from the bag, and let it thaw at room temperature. Remove the lid and mat gently. For long-term storage, tightly reseal with the mat, place in the resealable bag and purge with an inert gas. Store at -70°C in an upright position. Minimize freeze/thaw cycles. Product is stable for up to one year after receipt.
    Toxicity Regulatory Review
    Citation
  • Anastassiadis, T., et al. 2011. Nature Biotech. 29, 1039.
  • Cohen, T., et al. 2012. Biochem. J. in press.
  • Elkaim, J., 2012. Biochem. J. in press.
  • Baxter, B.K., et al. 2011. ACS Chem. Biol. in press.
  • Lanier, m. et al. 2011. J. Med. Chem. DOI: 10.1021/jm2010223.
  • Wong, S.W., et al. 2010. Breast Cancer Res. Treat. in press.
  • Chou, T-F. and Deshaies, R.J., 2011. JBC Papers in Press.
  • Li, T., et al. 2010. Anal. Chem. 82, 3067.
  • Johnson, J.L., et al. 2009.BMC Microbiol. 9, 218.
    		•